CAC Software vs Tempus ECG-AF
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if you need to precisely quantify coronary artery calcification from existing non-contrast chest CT scans to assess a patient's risk for coronary artery disease. It is ideal for radiologists and cardiologists seeking automated Agatston scores, arterial age, and 3D visualizations for detailed anatomical risk stratification.
View CAC Software →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if you are looking to identify patients aged 65 or older at increased risk of developing new-onset atrial fibrillation within the next 12 months, utilizing standard 12-lead ECG recordings. This is particularly useful for proactive screening and follow-up in geriatric or internal medicine settings to support earlier intervention for AF.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | Tempus ECG-AF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Cloud-based (SaaS), integrates with PACS | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CAC SoftwareImbio's CAC Software is designed for high usability, running automatically on CT images with no user input or intervention and integrating seamlessly into existing DICOM viewing workflows. This 'no user interface to learn' approach minimizes workflow disruption and provides results as DICOM or PDF reports with visualizations.
Clinical Value
Tempus ECG-AFTempus ECG-AF offers significant clinical value by identifying patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within the next 12 months from a standard 12-lead ECG. This predictive capability enables earlier identification and proactive follow-up, potentially leading to more timely and effective interventions for a high-impact condition.
Pricing & Value
Tempus ECG-AFWhile both tools require direct vendor contact for specific pricing, Tempus ECG-AF explicitly details available CMS reimbursement (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90, effective January 1, 2025). This transparency and established reimbursement pathway significantly enhance its value proposition for healthcare providers.
Enterprise Readiness
CAC SoftwareBoth tools are FDA cleared, HIPAA compliant, and offer Business Associate Agreements. However, Imbio's CAC Software explicitly lists diverse deployment options including Cloud, On-premise, and Partner platforms, offering greater flexibility for integration into various institutional IT infrastructures and preferences.
Innovation
Tempus ECG-AFBoth tools leverage advanced AI. Tempus ECG-AF stands out for its innovative application of AI to predict the risk of a future clinical event (AF onset within 12 months) from a widely available and inexpensive 12-lead ECG, trained on an extensive dataset of over 1.5 million ECGs.
Support & Docs
CAC SoftwareImbio provides a comprehensive support system, including a dedicated support page with phone numbers (US and India), email support, an online case submission form, and explicit mention of user manuals and other product documentation available upon request.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | Tempus ECG-AF |
|---|---|---|
| Name | CAC Software | Tempus ECG-AF |
| Company | Imbio | Tempus AI, Inc. |
| Description | Automated image post-processing algorithms to determine location and calculate amount of calcification within coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). | AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Key Functionality | Automated image post-processing for coronary artery calcification, quantification of calcification, outputs Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations and annotated images, non-invasive analysis from non-contrast chest CT scans, integrates into existing DICOM viewing workflow, supports risk assessment for coronary artery disease, deep-learning based analysis. | AI-based algorithm for 12-lead ECG analysis, detects signs associated with new onset Atrial Fibrillation (AF) within 12 months, intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, results interpreted in conjunction with other diagnostic information and clinical history, compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems, trained on over 1.5 million ECGs from over 500,000 patients. |
| Specialties | Cardiology, Radiology | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and Tempus ECG-AF.